Keyphrases
Treatment Response
100%
Overall Outcome
100%
Peptide Receptor Radionuclide Therapy
100%
Lutetium-177 (177Lu)
100%
DOTATATE
100%
Advanced Neuroendocrine Tumors
100%
Partial Response
83%
Stable Disease
25%
Pancreatic NET
25%
Well-differentiated Neuroendocrine Tumor
25%
Progressive Disease
16%
Radiation Exposure
16%
Response Rate
8%
Age at Diagnosis
8%
Bone Marrow
8%
Adjusted Odds Ratio
8%
Multivariable Model
8%
Tumor Stage
8%
Clinical High Risk
8%
Treatment Evaluation
8%
Small Intestine
8%
Treatment Cycle
8%
Tumor Grade
8%
Tumor Response
8%
Tumor Burden
8%
Therapy Evaluation
8%
Personalized Management
8%
Therapy Response
8%
Subsequent Chemotherapy
8%
Positron Emission Tomography/computerized Tomography
8%
RECIST 1.1
8%
Therapy Assessment
8%
68Ga-DOTATATE
8%
Advanced Wells
8%
Medicine and Dentistry
Treatment Response
100%
Neuroendocrine Tumor
100%
Suprofen
100%
Peptide Receptor
100%
Radionuclide Therapy
100%
Lutetium
100%
Diseases
25%
Neoplasm
16%
Progressive Disease
16%
Radiation Exposure
16%
Computer Assisted Tomography
8%
Retrospective Study
8%
Small Intestine
8%
Positron Emission Tomography
8%
Gallium 68
8%
Odds Ratio
8%
Psychology
Positron-Emission Tomography
100%
Computerized Tomography
100%
Immunology and Microbiology